News

The MDA and the CMTA today announced a research grant totaling $119,999 to Kleopas Kleopa, MD, for a study on the effectiveness of a gene therapy approach in the second most common form of Charcot-Marie-Tooth disease (CMT).

Invitae Corporation, a genetic information company, today announced it has expanded its neurology test offering, adding 11 new panels for heritable diseases and updating 17 existing neurology panels based on new discoveries in genetics research.

Dr. Louis Weimer of Columbia University recently updated the CMTA’s neurotoxic medication list as part of his review for an upcoming issue of Current Neurology and Neuroscience Reports.

When living with a condition that can add challenges to starting or maintaining a fitness program. One tool that can help is Balance Walking with Nordic walking poles—a great way to not only get and stay fit, but to make ...

Gilles Bouchard took the helm of the Charcot-Marie-Tooth Association March 16, saying that while he is “excited and delighted” with the progress made by the CMTA’s STAR research program, there’s still much work to be done.